Crosstex acquires SPSmedical

Nov. 2, 2012
Sterilization monitoring and assurance leaders unite.

HAUUPPAUGE, New York--Crosstex International, a subsidiary of Cantel Medical, has announced the acquisition of SPSmedical.

The move unites two of the leading North American providers of sterilization monitoring services and sterility assurance products in dental, acute-care, alternate-care and office based practitioner markets.

The addition of SPSmedical to the Crosstex family strengthens the Crosstex position in the acute-care and alternate-care markets while broadening the Crosstex sterility assurance product offering.

Based in Rochester, N.Y., SPS is a leading manufacturer and provider of biological and chemical indicators for sterility assurance monitoring services and products. SPS offers an array of products and services that enable hospitals, surgi-centers, office-based practitioners, and dental offices to safely and accurately monitor and verify their sterilization practices and protocols.

According to Gary Steinberg, president and CEO of Crosstex, “SPSmedical is the perfect complement to our ConFirm brand biologic monitoring business and will provide us with the platform to broaden our reach into the acute-care and alternate-care markets. SPS’ strong leadership in defining and establishing sterility assurance standards in healthcare settings is a strong platform upon which Crosstex can expand its global presence as a leader in the healthcare infection prevention and control market.”

Added Andrew Whitehead, senior vice president of business development: “The addition of SPS to the Crosstex family expands our presence in the acute-care and alternate-care markets, broadens our product portfolio, and strengthens our position in the dental market.

“Utilizing the strengths, reputations, and talent of the combined Crosstex and SPS teams, we will increase our market penetration into all health-care channels, both domestically and internationally.”

For more information, call (631) 582-6777 or visit

To comment on this topic, go to